Delivery Order V797P5025B-VA69D16F1140

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $97,386.93 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule. The order is for LU177 PLUVICTO - IC to be delivered to a location in Millburn, New Jersey by June 14, 2024. No set-aside designation was used for this award. Advanced Accelerator Applications USA Inc. will provide the...

This delivery order, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, is valued at approximately $194,773.86 to Advanced Accelerator Applications USA Inc. for the product PLUVICTO URGENT PATIENT(LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML). The firm fixed price order was issued against the company's Pharmaceuticals and Drugs schedule (FSS-61-IB) and has a completion date of May 26, 2023. No set-aside designation was used for...

This federal contract award is for LUTHATHERA LU 177 MEDICAL SUPPLIES and was awarded to the prime contractor, Advanced Accelerator Applications USA Inc. The contract has a ceiling value of $150,377.88 and was awarded on March 26, 2020, with an ultimate completion date of December 31, 2020. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The awarding agency is the Defense Health Agency (DHA), a component of the Department of Defense. Advanced...

This federal contract award is for the provision of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), a radiopharmaceutical product used in targeted radioligand therapy and nuclear medicine procedures. The contract was awarded to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products, operating as a subsidiary of Novartis. The contract was awarded by the Department of Veterans Affairs (VA), specifically through...

This federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, is for the delivery of six branded nuclear medicine products approved by the FDA, including LUTATHERA and PLUVICTO. The $498,438.38 firm-fixed-price purchase order has a completion date of December 4, 2025 and was awarded on December 4, 2024 by the Defense Health Agency (DHA), a defense agency. The contract is not set aside for small businesses. Advanced Accelerator Applications USA Inc. is a...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $4,031,438 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is for the delivery of 20 doses of Lutetium (Lu177) DOTATATE and 100 doses of Lutetium (Lu177) PSMA, with performance through February 5, 2025. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical...

Advanced Accelerator Applications USA Inc. was awarded a $117,781.05 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The firm fixed price order is for the delivery of LUTATHERA (LUTETIUM LU 177 DOTATATE) 3 DOSES to New York, NY by October 31, 2023. No set-aside designation was applied to this order to provide radiopharmaceutical drugs in support of...

This is a firm-fixed-price BPA call order awarded by the Defense Health Agency to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, for the delivery of Lutetium Lu 177 Dotatate doses for radiation therapy. The potential value of this order is $226,942.00, with a completion date of June 30, 2021. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that provides diagnostic and therapeutic radiopharmaceutical products and services to...

Advanced Accelerator Applications USA Inc. was awarded a $227,236 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Defense Health Agency. The delivery order is for seven units of PLUVICTOR (lutetium-177), a radiopharmaceutical drug, to be delivered to a location in New York by September 30, 2023. No set-aside provisions were applied to this award, which was issued on October 17, 2022 to support the Defense Health Agency's...

This is a federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, for the delivery of the radiopharmaceutical product PLUVICTO. The contract, valued at $2,979,818.10, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of October 31, 2025. This award is not set aside for small businesses. Advanced Accelerator Applications...